Pramipexole ER (CTC-413) is a small molecule that acts as a dopamine receptor agonist and NK-1 receptor antagonist to treat motor impairment and progression in Parkinson’s disease by modulating multiple neurotransmitter pathways.
Discover our Products
Science-based and high-quality devices
